Inhalational anthrax (bioterrorism)
Bioterrorism · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Bacillus anthracis spore inhalation causing a biphasic illness: flu-like prodrome then fulminant mediastinitis, haemorrhagic pleural effusions and shock. A deliberate-release/bioterrorism concern.
Red flags
- Widened mediastinum on imaging in a previously well patient
- Haemorrhagic pleural effusions
- Meningeal signs (haemorrhagic meningitis)
- Rapid progression to shock
Assessment
Differential diagnosis
- Community-acquired pneumonia
- Influenza/viral illness
- Aortic dissection (widened mediastinum)
- Tularaemia/plague (bioterrorism differentials)
- Mediastinitis (other)
Investigations
- Chest X-ray/CT (widened mediastinum, pleural effusions - not lobar infiltrate)
- Blood cultures and Gram stain (large Gram-positive rods)
- Pleural fluid analysis and culture
- Notify public health and reference laboratory urgently
- FBC, U&E, lactate, coagulation
Management
- Isolate concern early and notify public health / reference lab (person-to-person spread is not the issue but exposure investigation is)
- Resuscitate for sepsis; drain pleural effusions
- Start combination IV antibiotics including a protein-synthesis inhibitor to reduce toxin
- Add antitoxin (raxibacumab or anthrax immune globulin) per public health
- Give steroids if extensive oedema/meningitis
- ICU-level organ support
Drugs & doses
Ciprofloxacin IV plus clindamycin plus (if meningitis suspected) meropenem
Anthrax antitoxin (raxibacumab or obiltoxaximab) per public health
IV fluids and vasopressors as needed
Disposition
ICU; mandatory public health notification; prophylaxis planning for exposed contacts.
Complications & pitfalls
- Haemorrhagic meningitis
- Refractory shock and death
- Massive pleural effusions
Exam pearls
- Inhalational anthrax causes mediastinal widening rather than a classic pneumonia pattern.
- Multiple simultaneous cases suggest deliberate release - notify authorities immediately.
- Include a toxin-suppressing agent (e.g. clindamycin/linezolid) plus a bactericidal drug.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.